Whittier Trust CO Ultragenyx Pharmaceutical Inc. Transaction History

Whittier Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$45.8 - $85.4 $824 - $1,537	-18 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$62.2 - $84.4 $3,421 - $4,642	-55 Reduced 75.34%	18 $1,000
Q4 2021 Jan 19, 2022	BUY	$73.71 - $87.86 $5,380 - $6,413	73 New	73 $6,000
Q4 2019 Jan 31, 2020	SELL	$36.08 - $45.83 $2,669 - $3,391	-74 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$42.5 - $63.11 $3,145 - $4,670	74 New	74 $3,000

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.1B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.